| Preetinder S. Sandhu, Md, Llc | |
|
821 N Eutaw St Ste 305 Baltimore MD 21201-6303 | |
| (410) 362-4481 | |
| (410) 362-3647 |
| Full Name | Preetinder S. Sandhu, Md, Llc |
|---|---|
| Speciality | Internal Medicine |
| Location | 821 N Eutaw St Ste 305, Baltimore, Maryland |
| Authorized Official Name and Position | Preetinder Singh Sandhu (OWNER) |
| Authorized Official Contact | 4103624481 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Preetinder S. Sandhu, Md, Llc 821 N Eutaw St Ste 305 Baltimore MD 21201-6303 Ph: (410) 362-4481 | Preetinder S. Sandhu, Md, Llc 821 N Eutaw St Ste 305 Baltimore MD 21201-6303 Ph: (410) 362-4481 |
| NPI Number | 1093054298 |
|---|---|
| Provider Enumeration Date | 02/07/2013 |
| Last Update Date | 05/11/2021 |
| Medicare PECOS PAC ID | 4789821984 |
|---|---|
| Medicare Enrollment ID | O20130507000556 |
News Archive
In the first large-scale effort of its kind, researchers have determined the full genetic sequence of more than 200 distinct strains of human influenza virus.
Scientists at Forsyth, along with a colleague from Northwestern University, have discovered that the protein, Transgultaminase 2 (TG2), is a key component in the process of gum disease. TG2 is widely distributed inside and outside of human cells. The scientists found that blocking some associations of TG2 prevents the bacteria Porphyromonas gingivalis (PG) from adhering to cells. This insight may one day help lead to novel therapies to prevent gum disease caused by PG.
"Humanitarian agencies are warning of a looming food crisis in parts of the Central African Republic (CAR), a result of the insecurity that has displaced thousands of people and disrupted cultivation and trade," IRIN reports.
Each of the 6.7 billion people on Earth has a signature body odor - the chemical counterpart to fingerprints - and scientists are tracking down those odiferous arches, loops, and whorls in the "human odorprint" for purposes ranging from disease diagnosis to crime prevention. That's the topic of an article in the current issue of Chemical & Engineering News, ACS' weekly newsmagazine.
Mirna Therapeutics, Inc. announced today that the USPTO has allowed claims related to the therapeutic application of let-7 in the regulation of oncogenes. The claims derive from a patent application that was submitted by Yale University and exclusively licensed to Mirna related to the pioneering work of Dr. Frank Slack, Professor of Molecular, Cellular & Developmental Biology at Yale University in New Haven, CT.
› Verified 3 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093054298 | NPI | - | NPPES |
| 778204700 | Medicaid | MD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | D0057543 (Maryland) | Primary |
| Provider Name | Preetinder Sandhu |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1487628897 PECOS PAC ID: 6800852971 Enrollment ID: I20041209000839 |
News Archive
In the first large-scale effort of its kind, researchers have determined the full genetic sequence of more than 200 distinct strains of human influenza virus.
Scientists at Forsyth, along with a colleague from Northwestern University, have discovered that the protein, Transgultaminase 2 (TG2), is a key component in the process of gum disease. TG2 is widely distributed inside and outside of human cells. The scientists found that blocking some associations of TG2 prevents the bacteria Porphyromonas gingivalis (PG) from adhering to cells. This insight may one day help lead to novel therapies to prevent gum disease caused by PG.
"Humanitarian agencies are warning of a looming food crisis in parts of the Central African Republic (CAR), a result of the insecurity that has displaced thousands of people and disrupted cultivation and trade," IRIN reports.
Each of the 6.7 billion people on Earth has a signature body odor - the chemical counterpart to fingerprints - and scientists are tracking down those odiferous arches, loops, and whorls in the "human odorprint" for purposes ranging from disease diagnosis to crime prevention. That's the topic of an article in the current issue of Chemical & Engineering News, ACS' weekly newsmagazine.
Mirna Therapeutics, Inc. announced today that the USPTO has allowed claims related to the therapeutic application of let-7 in the regulation of oncogenes. The claims derive from a patent application that was submitted by Yale University and exclusively licensed to Mirna related to the pioneering work of Dr. Frank Slack, Professor of Molecular, Cellular & Developmental Biology at Yale University in New Haven, CT.
› Verified 3 days ago
News Archive
In the first large-scale effort of its kind, researchers have determined the full genetic sequence of more than 200 distinct strains of human influenza virus.
Scientists at Forsyth, along with a colleague from Northwestern University, have discovered that the protein, Transgultaminase 2 (TG2), is a key component in the process of gum disease. TG2 is widely distributed inside and outside of human cells. The scientists found that blocking some associations of TG2 prevents the bacteria Porphyromonas gingivalis (PG) from adhering to cells. This insight may one day help lead to novel therapies to prevent gum disease caused by PG.
"Humanitarian agencies are warning of a looming food crisis in parts of the Central African Republic (CAR), a result of the insecurity that has displaced thousands of people and disrupted cultivation and trade," IRIN reports.
Each of the 6.7 billion people on Earth has a signature body odor - the chemical counterpart to fingerprints - and scientists are tracking down those odiferous arches, loops, and whorls in the "human odorprint" for purposes ranging from disease diagnosis to crime prevention. That's the topic of an article in the current issue of Chemical & Engineering News, ACS' weekly newsmagazine.
Mirna Therapeutics, Inc. announced today that the USPTO has allowed claims related to the therapeutic application of let-7 in the regulation of oncogenes. The claims derive from a patent application that was submitted by Yale University and exclusively licensed to Mirna related to the pioneering work of Dr. Frank Slack, Professor of Molecular, Cellular & Developmental Biology at Yale University in New Haven, CT.
› Verified 3 days ago
Empowerment Healthcare Systems,llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 9106 Philadelphia Rd Ste 108b, Baltimore, MD 21237 Phone: 410-698-8284 Fax: 410-321-1962 | |
Fresh Start Comprehensive Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 11 E Mount Royal Ave # Ll, Baltimore, MD 21202 Phone: 443-671-1414 Fax: 443-671-1420 | |
Gbmc Health Partners At Jonestown Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1017 E Baltimore St, Ground Floor, Baltimore, MD 21202 Phone: 410-826-0170 | |
Admin Location Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2024 E Monument St Ste 2626, Baltimore, MD 21287 Phone: 410-933-6430 | |
Plume Health Pc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 200 E Pratt St, Baltimore, MD 21202 Phone: 720-248-4483 | |
Np Medical Solutions By Sheila Waller Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 5119 Mcfaul Rd, Baltimore, MD 21206 Phone: 443-531-6248 | |
Health Care For The Homeless, Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 421 Fallsway, Baltimore, MD 21202 Phone: 410-837-5533 Fax: 410-837-8020 |